Achievements of Department of Biotechnology - Year End Review 2025
Key Points
The Department of Biotechnology (DBT) has made significant achievements in 2025, with India's biotechnology sector poised to reach a bio-economy worth USD 300 billion by 2030. This matters for UPSC aspirants as it relates to GS Paper 3, focusing on Science & Technology. Last Updated: 2025-12-18
Key Facts About Achievements of Department of Biotechnology
- Biotechnology Growth: Bio-economy surged from USD 10 billion in 2014 to over USD 165.7 billion in 2024.
- Publications & Patents: Reports on publications and patents to be released in March 2026.
- Healthcare Innovations: Early-stage vaccine candidates for Chikungunya, Coronavirus, and Monkeypox developed.
- Vaccine Research Infrastructure: Established at BRIC-THSTI with a BSL-3 facility.
- Emerging Frontiers: 123 projects funded to address scientific challenges.
- North Eastern Region: Empowered Institutional Biosafety Committees with monitoring via IBKP portal.
- Space Biomanufacturing: Microgravity research conducted to enhance astronaut nutrition.
- Centre-State BioE3 Cells: Initiated to boost biotechnology innovations.
India's Biotechnology Growth and Global Standing
The biotechnology sector in India is a key driver of economic growth, aligning with national goals of innovation and self-reliance. With a projected bio-economy of USD 300 billion by 2030, India ranks 12th globally and 3rd in the Asia-Pacific for biotechnology. This growth is supported by international collaborations and a robust public-private partnership framework, positioning India as a leader in vaccine manufacturing.
Related Government Schemes/Policies
- BioE3 Policy: Promotes sustainable bioeconomy through six thematic sectors.
- Public-Private Partnerships: Strengthened to support biotechnology sector growth.
UPSC Relevance
- GS Paper 3: Science & Technology - Developments and their applications and effects in everyday life.
- Prelims Angle: Questions on India's global ranking in biotechnology, key projects, and vaccine development initiatives.
- Mains Angle: Analytical themes on the role of biotechnology in economic growth and public health.
- Essay Paper: Topics on innovation and technology in India's development.
FAQ Section
- What is the Department of Biotechnology? The Department of Biotechnology (DBT) is a government department in India responsible for promoting and regulating biotechnology development and innovation.
- Why is biotechnology important? Biotechnology is crucial for economic growth, healthcare advancements, and sustainable development, with India projected to achieve a bio-economy worth USD 300 billion by 2030.
- What are the key features of DBT's achievements in 2025? Key features include vaccine development, international collaborations, and the establishment of research infrastructure like the BSL-3 facility at BRIC-THSTI.
Detailed Coverage
- Biotechnology Growth: Bio-economy surged from USD 10 billion in 2014 to over USD 165.7 billion in 2024.
- Publications & Patents: Reports on publications and patents to be released in March 2026.
- Healthcare Innovations: Early-stage vaccine candidates for Chikungunya, Coronavirus, and Monkeypox developed.
- Vaccine Research Infrastructure: Established at BRIC-THSTI with a BSL-3 facility.
- Emerging Frontiers: 123 projects funded to address scientific challenges.
- North Eastern Region: Empowered Institutional Biosafety Committees with monitoring via IBKP portal.
- Space Biomanufacturing: Microgravity research conducted to enhance astronaut nutrition.
- Centre-State BioE3 Cells: Initiated to boost biotechnology innovations.
- International Collaborations: Established with the UK (FEMTECH) and Switzerland (One Health).
- BioE3 Policy: Promotes sustainable bioeconomy through six thematic sectors.
- Public-Private Partnerships: Strengthened to support biotechnology sector growth.
- Training Initiatives: 744 human resources trained in biotechnology.
- New Projects: 3516 new projects sanctioned to foster innovation.
- India's Ranking: 12th in the world and 3rd in Asia-Pacific for biotechnology.
- Vaccine Manufacturing: India is the largest vaccine manufacturer globally.
- Projected Sector Value: USD 300 billion by 2030.